We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Herceptin–Chemotherapy Drug Combo Keeps Women’s Breast Cancers at Bay

News   Jul 01, 2019 | Original story from ICR

 
Herceptin–Chemotherapy Drug Combo Keeps Women’s Breast Cancers at Bay
 
 
 

RELATED ARTICLES

Why Are Some People More Receptive to Vaccination?

News

Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study.

READ MORE

HIV Vaccine Is a Step Closer to Clinical Trials

News

A promising vaccine that clears an HIV-like virus from monkeys is a step closer to human testing after a new, weakened version of the vaccine has been shown to provide similar protection as its original version.

READ MORE

Deadliest Cancers Receive the Least Amount of Research Funding

News

Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new study that examined the distribution of nonprofit cancer research funding in 2015 across cancer types.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE